Belgium-based Materialise has announced that its TRUMATCH 3D printed titanium maxillofacial implants have been approved for use in the USA.
The TRUMATCH implants are part of a complete solution for personalized orthognathic—otherwise referred to as corrective jaw—and facial reconstructive surgeries. The solution draws on Materialise’s software development, clinical engineering and 3D printing production services, covering initial virtual surgical planning to 3D printing of the implants as well as accompanying surgical guides.
Since its introduction in 2016, the solution has achieved excellent aesthetic results as well as minimized surgery time in both the Australian and European markets.
The implants are to be distributed under the TRUMATCH CMF brand by Materialise’s long-standing partner DePuy Synthes, part of Johnson & Johnson Medical Devices and a provider of orthopedic and neuro products and services.
‘As the first of our extensive selection of implants to receive clearance for the US markets, the decision is a real milestone for our medical department,’ said Brigitte de Vet, vice president (VP) of Materialise Medical. ‘Thanks to our partnership with DePuy Synthes, our devices will be able to provide better healthcare for as many patients as possible.’
‘For seven years now I’ve experienced the benefits of 3D-printed implants firsthand,’ said Dr. Thomas Schouman, craniomaxillofacial (CMF) surgeon at Groupe Hospitalier Pitié Salpêtrière, France. ‘They simplify maxillofacial surgery and allow me to perform procedures more accurately, saving time in the OR and improving patient outcomes. Moreover, they offer new treatment possibilities, allowing me to perform more complex surgeries or multiple procedures in a single intervention whereas without the implants several interventions would be necessary.’